Management of Beta Blocker Therapy in First-Degree AV Block

Assessment and Monitoring

Patients with first-degree AV block on beta blockers should be evaluated for presence of symptoms, such as dizziness or lightheadedness, and signs of hypoperfusion, including confusion or hypotension 1
The PR interval duration, especially if greater than 300 ms, should be monitored in patients with first-degree AV block on beta blockers 2

For asymptomatic first-degree AV block with a PR interval less than 300 ms, the current beta blocker dose can be continued, with regular monitoring of heart rate and rhythm 2, 3
If the PR interval is 300 ms or greater in an asymptomatic patient, consideration should be given to reducing the beta blocker dose, with ongoing monitoring for symptom development 1
For symptomatic first-degree AV block, the beta blocker dose should be reduced, with monitoring for improvement in symptoms 1
In cases of significant PR interval prolongation greater than 300 ms with symptoms, reduction of the beta blocker dose is recommended, and pacemaker implantation may be considered if symptoms are consistent with pacemaker syndrome 2

Elderly patients, 75 years or older, may require lower maintenance doses of beta blockers due to increased susceptibility to bradycardia and conduction disorders 1
Beta-1 selective agents may be preferred due to fewer peripheral vascular effects 5
The medication list should be reviewed for other drugs that may exacerbate bradycardia or heart block 1

Pacemaker implantation may be considered in patients with symptomatic first-degree AV block and a significantly prolonged PR interval 2
Evaluation for permanent pacemaker implantation is recommended if second- or third-degree heart block develops 2, 4